Past Events

Mining the post-mortem human brain for neurodegenerative marker: high throughput deep sequencing of cell type specific transcriptomes

This webinar will highlight the use of high-throughput sequencing of post-mortem human brain tissue to identify neurodegenerative markers and identify potential drug targets. Dr. Steve Sheardown, Head of Molecular Biology and Cell Engineering at pharmaceutical company Cerevance, will discuss a technology platform called NETSseq (Nuclear Enriched Transcript Sort sequencing). Cerevance uses NETSseq to interrogate the molecular diversity of individual neuronal cell types in human tissue to understand their genetic complexity, the contribution that each of these make to circuit function, and, in the context of brain disorders, their potential for therapeutic intervention. Cerevance is building an extensive collection of transcriptomes from cell types selected for relevance to human disease covering both sexes and spanning different ages from donor samples obtained from diseased populations. Since commencing clinical data collection in October 2017, Cerevance have already accumulated over 1,300 high quality individual transcriptomes. Using this unique resource, the company aims to identify and pursue novel drug targets to address areas of high unmet medical need within the field of central nervous system disorders. Dr. Sheardown will discuss how his team has transformed NETSseq from a low-throughput proof of concept to a robust high-throughput process for generating deep sequencing libraries from limited quantities of fixed post-mortem tissue. To achieve this, Cerevance has rigorously tested a range of products at every stage of the process, focusing on yield, quality, reproducibility, and automatability. Drawing on examples from the company's transcriptome dataset, Dr. Sheardown will illustrate the depth of information that his team can generate using its NETSseq platform. Click here to register.

May 10, 2018

ABRF 2018

The Premier Conference for Core Services will bring together international leaders in our core disciplines to provide a vision of what can be done, and insight toward making further progress as we work in the present.​  We are excited to share information about our new product Celero DNA-Seq and the innovative quantitation method - NuQuant - included with every Celero kit. NuQuant will soon be available with Universal Plus! Visit us at our booth #420 and snag some great giveaways and enter to win a GoPro!

Myrtle Beach April 22 - 25, 2018


Join us for the 2018 Plant and Animal Genome (PAG) XXVI Conference in San Diego, California! We are once again hosting an exciting workshop where we will highlight how Allegro Targeted Genotyping is being used to answer emerging questions in agricultural research. Come meet our team and learn how Allegro provides high sample mulitplexing, the ability to interrogate over 100,000 SNPs in a single assay, and incredibly flexible design possibilities for targeting new markers. Stop by our booth (#107) to learn about recent advances in genotyping, RNA-Seq and other NGS applications and of course collect some great PAG swag! Check out our poster (#) "NuGEN’s Allegro Targeted Genotyping: A sensitive and cost-effective sequencing workflow for any genome." Presented by Michael Lovci, PhD Bioinformatics Scientist.

Town and Country Hotel, San Diego, CA January 13 - 17, 2018 Meet us at the booth to collect the survival kit

Characterization of Gene Fusions in Distinct Subtypes of Melanoma

This webinar describes the characterization of gene fusions across distinct subtypes of melanoma. The majority of common sun exposure-related melanomas have high mutational burden and activating mutations in the BRAF kinase gene. In contrast, less common subtypes of melanoma not related to sun exposure (acral lentiginous and mucosal melanomas) have low mutation burden, generally lack BRAF mutations, and have increased frequency of genomic structural variants. Activating gene fusions in BRAF have been reported in melanomas lacking mutations in BRAF and other common melanoma driver genes, but gene fusions and their therapeutic potential have not been well studied across different subtypes of melanoma. To characterize gene fusions, Kasey Couts and colleagues at the University of Colorado Anschutz Medical Campus performed targeted RNA sequencing of 65 melanoma patient-derived xenograft (PDX) models representing different melanoma subtypes (sun-exposed and non-sun-exposed) and genotypes (with or without common driver mutations). They identified several kinase gene fusions in melanomas lacking other driver mutations and tested the therapeutic potential in pre-clinical models using specific small molecule inhibitors. During this webinar, Dr. Couts will describe the gene fusion targeted RNA sequencing screen and discuss the results, which include identification of an ALK fusion (EML4-ALK) occurring in a malignant melanoma. She also discusses the successful response to targeted inhibitors in melanomas with various kinase fusions. This webinar highlights the clinically significant finding of targetable gene fusions in both sun-exposed and non-sun-exposed subtypes of melanoma. Click here to register.

July 20, 2017

European Society for Human Genetics Annual Meeting

ESHG 2017 marks the 50th Anniversary of the first European Society of Human Genetics Conference which took place in Copenhagen in 1967. In commemoration of this event, the organizers have chosen the Bella Center in Denmark’s capital as the venue this historic meeting. The scientific schedule for ESHG 2017 is packed with outstanding speakers and presentations highlighting the latest findings in the field of basic and applied human genetics. Join us for what will certainly be an engaging and highly informative meeting!  Stop by the exhibit hall, booth #646 and learn about our latest advancements in NGS to better enable your genetic studies! Learn about our solutions for: Our exciting new products in our RNA-Seq portfolio; Universal Plus mRNA-Seq, an enhanced mRNA-Seq method with customizable depletion, ideal for Blood mRNA-Seq studies Trio RNA-Seq, a high sensitivity whole transcriptome approach ideally suited for viral discovery and detection The fastest, simplest DNA-Seq workflow - Ovation® Ultralow System V2 Highly sensitivity NGS methods for Methyl-Seq epigenetics - Ovation® RRBS Methyl-Seq Our patented SPET technology for Targeted Genotyping and Gene Fusion analysis   The exhibit hall hours are as follows: Sunday 28th May 08.30 - 21.30 hrs Monday 29th May 08.30 - 19.15 hrs Tuesday 30th May 09.00 - 16.00 hrs      

Copenhagen, Denmark May 27 - 30, 2017

qPCR, dPCR and NGS 2017

The great international interest in the previous qPCR dPCR & NGS Events from 2004 till 2015 with a constant audience of more than 500 participants from all over the world motivates repeating the success next year in April 2017. 

Freising Weihenstephan, Germany April 03 - 07, 2017

28th Annual Meeting of the German Society for Human Genetics (GfH)

Join us for the 28th annual meeting of the German Society for Human Genetics. The GfH, founded in 1987, is the primary professional membership organization for human geneticists in Germany. With more than 1000 professional members, the GfH Society brings a diverse group of researchers together including academics, clinicians, laboratory practice professionals, genetic counselors and others involved in or with special interest in human genetics. We will be hosting a Technical Workshop entitled Getting the Most out of RNA-Seq by Douglas Amorese. 

Bochum, Germany March 29 - 31, 2017


ABRF 2017, "A forum for advancing today’s core technologies to enable tomorrow’s innovations," will bring together international leaders in our core disciplines to provide a vision of what can be done, and insight toward making further progress as we work in the present. Visit us at our booth #601 and snag some great giveaways!

San Diego, CA March 25 - 28, 2017

5th Plant Genomics and Gene Editing Congress Europe

Global Engage is pleased to announce as part of their Plant Science series, the 5th Plant Genomics and Gene Editing Congress Europe, which will be held on 16-17 March 2017 in Amsterdam, the Netherlands. Joe Don Heath will be presenting a talk entitled Trait to Table: NSG Solutions for Targeted Genotyping and Transcriptomics on the 16th of March at 15:40. Come and visit us at our booth to learn more about recent advances in genotyping and RNA-Seq enabling agricultural research.  Targeted genotyping Species specific RNA-Seq  Highly sensitive Methyl-Seq  

Amsterdam, The Netherlands March 16 - 17, 2017

Insights into Genomic Imprinting: Studying Parental-Specific Epigenomes in Plants

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks. Parental-specific epigenetic marks are established in the gametes and maintained after fertilization, resulting in parental epigenetic asymmetry. Epigenetic asymmetry causes parent-of-origin-specific gene expression, a phenomenon termed genomic imprinting. Imprinted genes play an important role in animal and plant development. In plants, genomic imprinting occurs in the seed, particularly in the endosperm, an ephemeral tissue that supports embryo growth similarly to the nourishing role of the mammalian placenta. Scheduling conflict? You can still participate! All registrants will receive a link to view an on demand recording of the event.  Missed our webinar? View it here! Questions? Contact

February 23, 2017